Quantcast

Latest treatment of multiple sclerosis Stories

2014-03-17 23:04:21

Crowdfunding Site Targeted to Raise $300K for FDA-Approved Adult Stem Cell Trial New York, NY (PRWEB) March 17, 2014 The Tisch MS Research Center of New York (Tisch MSRCNY) today announced that they have launched a dedicated campaign on Indiegogo to raise funds for their FDA-Approved Phase I Clinical Stem Cell Trial. The non-profit research center aims to raise $300K to be directly applied to the first twenty patients selected to participate in the clinical trial. “We are excited to...

2014-03-10 08:28:58

ROCKVILLE, Md., March 10, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and other diseases, announced today that the U.S. Patent & Trademark Office has issued U.S. Patent No. 8,658,627 entitled, Pregnancy Hormone Combination for Treatment of Autoimmune Diseases, to the Regents of the University of California (UCLA). The patent includes claims to...

2014-02-28 23:02:01

DailyGossip.org reveals that multiple sclerosis is a complex condition that causes numerous symptoms. The magazine publishes a review to the Multiple Sclerosis Treatment, the newest natural remedy that provides fast symptoms relief. Denver, CO (PRWEB) February 28, 2014 According to http://www.DailyGossip.org, multiple sclerosis is a condition that can be developed by any individual. The disease is formed when the immune system attacks the protective sheath that covers the nerves. A...

2014-02-27 08:29:40

MISSISSAUGA, ON, Feb. 27, 2014 /CNW/ - Genzyme, a Sanofi company, today announced the Canadian availability of (Pr)LEMTRADA(TM) (alemtuzumab) for the management of adult patients with relapsing-remitting multiple sclerosis (RRMS), with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies. LEMTRADA 12 mg has a dosing and administration schedule of two annual treatment courses. The first...

2014-01-29 08:30:04

Copayment Assistance Now Available to Medicare Patients Living with Multiple Sclerosis GAITHERSBURG, Md., Jan. 29, 2014 /PRNewswire/ -- The HealthWell Foundation, an independent non-profit providing nationwide financial assistance to insured Americans with high out-of-pocket medication expenses, today announced the launch of a new fund to assist people with multiple sclerosis (MS). MS is a chronic, often disabling disease that attacks the central nervous system. The fund provides...

Multiple Sclerosis Patients Could Benefit From Increased Vitamin D Intake
2014-01-21 05:04:08

Karen Feldscher, Harvard School of Public Health For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health (HSPH) investigators in collaboration with Bayer HealthCare. The findings suggest that patients in the early stages of MS could stave off disease symptoms by increasing their vitamin D intake. "Because low vitamin D...

2013-11-30 23:01:17

http://www.DailyGossip.org reveals that multiple sclerosis is a complex condition that causes numerous symptoms. The magazine publishes a review to the Multiple Sclerosis Treatment, the newest natural remedy that provides fast symptoms relief. Denver, CO (PRWEB) November 30, 2013 According to DailyGossip.org review published on November 30, multiple sclerosis is a condition that can be developed by any individual. The "Multiple Sclerosis Treatment" review on DailyGossip.org...

2013-11-14 23:04:03

Reportbuyer.com just published a new market research report: Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules. London (PRWEB) November 14, 2013 The multiple sclerosis treatment landscape has undergone dramatic changes over the past year. Biogen’s Tecfidera has revolutionised multiple sclerosis treatment in the U.S., eroding significant market share from older therapies. However, patent concerns has stalled Tecfidera’s launch in Europe. Genzyme have taken advantage of...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related